139 related articles for article (PubMed ID: 12531328)
1. Prospects and challenges for prophylactic and therapeutic HIV vaccines.
Klein M
Vaccine; 2003 Jan; 21(7-8):616-9. PubMed ID: 12531328
[TBL] [Abstract][Full Text] [Related]
2. Current progress in the development of human immunodeficiency virus vaccines: research and clinical trials.
Klein M
Vaccine; 2001 Mar; 19(17-19):2210-5. PubMed ID: 11257335
[TBL] [Abstract][Full Text] [Related]
3. New CD4+ and CD8+ T cell responses induced in chronically HIV type-1-infected patients after immunizations with an HIV type 1 lipopeptide vaccine.
Gahery H; Daniel N; Charmeteau B; Ourth L; Jackson A; Andrieu M; Choppin J; Salmon D; Pialoux G; Guillet JG
AIDS Res Hum Retroviruses; 2006 Jul; 22(7):684-94. PubMed ID: 16831093
[TBL] [Abstract][Full Text] [Related]
4. Multiprotein HIV type 1 clade B DNA/MVA vaccine: construction, safety, and immunogenicity in Macaques.
Smith JM; Amara RR; McClure HM; Patel M; Sharma S; Yi H; Chennareddi L; Herndon JG; Butera ST; Heneine W; Ellenberger DL; Parekh B; Earl PL; Wyatt LS; Moss B; Robinson HL
AIDS Res Hum Retroviruses; 2004 Jun; 20(6):654-65. PubMed ID: 15242543
[TBL] [Abstract][Full Text] [Related]
5. [Vaccines against HIV].
Holm-Hansen C
Tidsskr Nor Laegeforen; 2006 Nov; 126(23):3117-20. PubMed ID: 17160118
[TBL] [Abstract][Full Text] [Related]
6. Different patterns of immune responses but similar control of a simian-human immunodeficiency virus 89.6P mucosal challenge by modified vaccinia virus Ankara (MVA) and DNA/MVA vaccines.
Amara RR; Villinger F; Staprans SI; Altman JD; Montefiori DC; Kozyr NL; Xu Y; Wyatt LS; Earl PL; Herndon JG; McClure HM; Moss B; Robinson HL
J Virol; 2002 Aug; 76(15):7625-31. PubMed ID: 12097576
[TBL] [Abstract][Full Text] [Related]
7. The improved antibody response against HIV-1 after a vaccination based on intrastructural help is complemented by functional CD8+ T cell responses.
Storcksdieck genannt Bonsmann M; Niezold T; Hannaman D; Überla K; Tenbusch M
Vaccine; 2016 Apr; 34(15):1744-51. PubMed ID: 26945099
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic HIV vaccines: prior setbacks, current advances, and future prospects.
Fisher AK; Voronin Y; Jefferys R
Vaccine; 2014 Sep; 32(43):5540-5. PubMed ID: 24968157
[No Abstract] [Full Text] [Related]
9. Prospects for an AIDS vaccine: three big questions, no easy answers.
Garber DA; Silvestri G; Feinberg MB
Lancet Infect Dis; 2004 Jul; 4(7):397-413. PubMed ID: 15219551
[TBL] [Abstract][Full Text] [Related]
10. Prospect of a prophylactic vaccine for HIV.
Hanke T
Br Med Bull; 2001; 58():205-18. PubMed ID: 11714632
[TBL] [Abstract][Full Text] [Related]
11. Status of vaccine research and development of vaccines for HIV-1.
Safrit JT; Fast PE; Gieber L; Kuipers H; Dean HJ; Koff WC
Vaccine; 2016 Jun; 34(26):2921-2925. PubMed ID: 26993335
[TBL] [Abstract][Full Text] [Related]
12. HIV/AIDS vaccines: 2007.
Robinson HL
Clin Pharmacol Ther; 2007 Dec; 82(6):686-93. PubMed ID: 17971817
[TBL] [Abstract][Full Text] [Related]
13. A prime-boost approach to HIV preventive vaccine using a recombinant canarypox virus expressing glycoprotein 160 (MN) followed by a recombinant glycoprotein 160 (MN/LAI). The AGIS Group, and l'Agence Nationale de Recherche sur le SIDA.
Pialoux G; Excler JL; Rivière Y; Gonzalez-Canali G; Feuillie V; Coulaud P; Gluckman JC; Matthews TJ; Meignier B; Kieny MP
AIDS Res Hum Retroviruses; 1995 Mar; 11(3):373-81. PubMed ID: 7598771
[TBL] [Abstract][Full Text] [Related]
14. Vaccination with a Shigella DNA vaccine vector induces antigen-specific CD8(+) T cells and antiviral protective immunity.
Shata MT; Hone DM
J Virol; 2001 Oct; 75(20):9665-70. PubMed ID: 11559798
[TBL] [Abstract][Full Text] [Related]
15. Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review.
Girard MP; Osmanov S; Assossou OM; Kieny MP
Vaccine; 2011 Aug; 29(37):6191-218. PubMed ID: 21718747
[TBL] [Abstract][Full Text] [Related]
16. HIV preventive vaccines. Progress to date.
Esparza J; Osmanov S; Heyward WL
Drugs; 1995 Nov; 50(5):792-804. PubMed ID: 8586027
[TBL] [Abstract][Full Text] [Related]
17. Mucosal and systemic HIV-1 Env-specific CD8(+) T-cells develop after intragastric vaccination with a Salmonella Env DNA vaccine vector.
Shata MT; Reitz MS; DeVico AL; Lewis GK; Hone DM
Vaccine; 2001 Nov; 20(3-4):623-9. PubMed ID: 11672930
[TBL] [Abstract][Full Text] [Related]
18. Vaccines based on Nef and on Nef/DeltaV2 Env.
Erfle V; Goebel FD; Guzman CA; Le Grand R
Microbes Infect; 2005 Nov; 7(14):1400-4. PubMed ID: 16243564
[TBL] [Abstract][Full Text] [Related]
19. AIDS vaccine boosts immunity in HIV patients.
RN; 1991 Oct; 54(10):103. PubMed ID: 1925340
[No Abstract] [Full Text] [Related]
20. HIV Env conserved element DNA vaccine alters immunodominance in macaques.
Hu X; Valentin A; Rosati M; Manocheewa S; Alicea C; Chowdhury B; Bear J; Broderick KE; Sardesai NY; Gall SL; Mullins JI; Pavlakis GN; Felber BK
Hum Vaccin Immunother; 2017 Dec; 13(12):2859-2871. PubMed ID: 28678607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
